Global Biologics Market Forecast 2025-2030: Growth at 8.25% CAGR Expected
Global Biologics Market Overview: 2025-2030
Base Year: 2024
Historical Years: 2020–23
Forecast Years: 2025-2030
The Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
Global Biologics Market Dynamics: 2025-2030
Global Biologics Market Driver:
Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.
Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/global-biologics-market.html
Global Biologics Market (2025-30): Segmentation Outlook
The market report has segmented the market into the following categories:
By Therapeutic Application
-Oncology- Market Size & Forecast 2020-2030, (USD Million)
-Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
-Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
-Diabetes- Market Size & Forecast 2020-2030, (USD Million)
-Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
-Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)
The Oncology segment witnessed substantial market growth during historical years.
By Drug Class
-Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
-Hormones- Market Size & Forecast 2020-2030, (USD Million)
-Cytokines- Market Size & Forecast 2020-2030, (USD Million)
-Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
-Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
-Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
-Vaccines- Market Size & Forecast 2020-2030, (USD Million)
-Others- Market Size & Forecast 2020-2030, (USD Million)
By Source
-Microbes- Market Size & Forecast 2020-2030, (USD Million)
-Humans- Market Size & Forecast 2020-2030, (USD Million)
-Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)
By Region
-North America
-South America
-Europe
-The Middle East & Africa
-Asia-Pacific.
North America held the major share of the Global Biologics Market. The dominance of North America has been attributed to its sturdy healthcare infrastructure & great investments in biopharmaceutical studies.
Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Global Biologics Market:
-Bristol-Myers Squibb
-Pfizer
-Sanofi
-Janssen Biotech, Inc.
-Bayer AG
-Merck & Co.
-Amgen Inc.
-Abbott GmbH
-Novartis
-AstraZeneca Plc
-GlaxoSmithKline Biologicals
-Moderna, Inc.
-Ferring Pharmaceuticals Inc.
-Aimmune Therapeutics, Inc.
-F. Hoffman La Roche.
Industry Recent Developments
- 2023: Amgen announced the completion of the acquisition of biologics market player, Horizon Therapeutics, which is aligned with its vision for the development of drugs for patients with rare diseases.
- 2023: AstraZeneca Plc. announced that the Ministry of Health, Labour, and Welfare in Japan approved the extended utilization of Soliris (eculizumab) biologics in the treatment of pediatric patients laid low with generalized myasthenia gravis, particularly those who have no longer responded nicely to different treatment options.
Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
